"ICON Public Limited Company (NASDAQ:ICLR): The stock pulled back on news that biotechnology funding has dropped, albeit from ...

Kalkine Nasdaq Futures ShowICON Public Limited (NASDAQ:ICLR), a key player in the clinical research and contract research ...

It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1989 and is ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...

Don't Miss out on Research Tools: Joseph Stringer has given his Buy rating due to a combination of factors related to Vir Biotechnology’s recent developments and data presentations. The company ...

UNITY Biotechnology (UBX) announced that Yehia Hashad, M.D., executive vice president of research and development and chief medical officer at Bausch + Lomb, has been appointed to the Company’s ...

Creating a biotechnology company that lasts depends on the ability to balance management, capital, and technology. History has proven that starting a new biotechnology company is not an activity ...

Integral Dental has announced the launch of its first product, Oracle PI, which according to the company is the only early diagnostic test for peri-implantitis. The test delivers a disease diagnosis ...

The U.S.-based biotechnology company is also known for its ambitious goal of bringing back the extinct woolly mammoth by 2028. This dire wolf pup is among the first of its species born in around ...

Bloomage Biotechnology Corp. Ltd. is an investment holding company, which engages in the production and sale of raw materials and end products for a diversified range of hyaluronic acid (HA ...